The Discounted Cash Flow (DCF) valuation of Cytokinetics Inc (CYTK) is (193.17) USD. With the latest stock price at 61.70 USD, the upside of Cytokinetics Inc based on DCF is -413.1%.
Based on the latest price of 61.70 USD and our DCF valuation, Cytokinetics Inc (CYTK) is a sell. selling CYTK stocks now will result in a potential gain of 413.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 8.8% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (817.00) - (113.44) | (193.17) |
| Upside | -1424.1% - -283.9% | -413.1% |